Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2014 1
2015 1
2016 2
2017 1
2019 1
2020 4
2021 5
2022 6
2023 4
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean piccardi l (173 results)?
Mechanisms of hypoxaemia in severe pulmonary hypertension associated with COPD.
Piccari L, Blanco I, Torralba Y, Arismendi E, Gistau C, Ramírez A, Gimeno-Santos E, Roca J, Burgos F, Rodríguez-Roisín R, Barberà JA. Piccari L, et al. Eur Respir J. 2023 Jul 20;62(1):2300463. doi: 10.1183/13993003.00463-2023. Print 2023 Jul. Eur Respir J. 2023. PMID: 37414421 Free PMC article.
Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
Smolders VFED, Rodríguez C, Blanco I, Szulcek R, Timens W, Piccari L, Roger Y, Hu X, Morén C, Bonjoch C, Sebastián L, Castellà M, Osorio J, Peinado VI, Bogaard HJ, Quax PHA, Cascante M, Barberà JA, Tura-Ceide O. Smolders VFED, et al. Among authors: piccari l. Sci Rep. 2022 Feb 10;12(1):2283. doi: 10.1038/s41598-022-06238-z. Sci Rep. 2022. PMID: 35145193 Free PMC article.
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension.
Piccari L, Allwood B, Antoniou K, Chung JH, Hassoun PM, Nikkho SM, Saggar R, Shlobin OA, Vitulo P, Nathan SD, Wort SJ. Piccari L, et al. Pulm Circ. 2023 Apr 1;13(2):e12213. doi: 10.1002/pul2.12213. eCollection 2023 Apr. Pulm Circ. 2023. PMID: 37025209 Free PMC article. Review.
Pulmonary vasculature in COPD: The silent component.
Blanco I, Piccari L, Barberà JA. Blanco I, et al. Among authors: piccari l. Respirology. 2016 Aug;21(6):984-94. doi: 10.1111/resp.12772. Epub 2016 Mar 30. Respirology. 2016. PMID: 27028849 Free article. Review.
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
Ghofrani HA, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberá JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM; NEW COLLABORATORS LIST. Ghofrani HA, et al. Respir Med. 2021 Mar;178:106220. doi: 10.1016/j.rmed.2020.106220. Epub 2020 Nov 12. Respir Med. 2021. PMID: 33540340 Free article.
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.
Kawano-Dourado L, Kulkarni T, Ryerson CJ, Rivera-Ortega P, Baldi BG, Chaudhuri N, Funke-Chambour M, Hoffmann-Vold AM, Johannson KA, Khor YH, Montesi SB, Piccari L, Prosch H, Molina-Molina M, Sellares Torres J, Bauer-Ventura I, Rajan S, Jacob J, Richards D, Spencer LG, Wendelberger B, Jensen T, Quintana M, Kreuter M, Gordon AC, Martinez FJ, Kaminski N, Cornelius V, Lewis R, Adams W, Jenkins G; REMAP-ILD consortium. Kawano-Dourado L, et al. Among authors: piccari l. Thorax. 2024 Mar 6:thorax-2023-221148. doi: 10.1136/thorax-2023-221148. Online ahead of print. Thorax. 2024. PMID: 38448221 Free article. Review.
ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly.
Lichtblau M, Piccari L, Ramjug S, Bokan A, Lechartier B, Jutant EM, Barata M, Garcia AR, Howard LS, Adir Y, Delcroix M, Jara-Palomares L, Bertoletti L, Sitbon O, Ulrich S, Vonk Noordegraaf A. Lichtblau M, et al. Among authors: piccari l. ERJ Open Res. 2022 May 23;8(2):00665-2021. doi: 10.1183/23120541.00665-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35615412 Free PMC article. Review.
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
Shlobin OA, Shen E, Wort SJ, Piccari L, Scandurra JA, Hassoun PM, Nikkho SM, Nathan SD. Shlobin OA, et al. Among authors: piccari l. Pulm Circ. 2024 Jan 10;14(1):e12310. doi: 10.1002/pul2.12310. eCollection 2024 Jan. Pulm Circ. 2024. PMID: 38205098 Free PMC article. Review.
31 results